Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.316 EUR | -3.66% | -2.77% | -12.22% |
04-17 | Intrasense: an innovative solution for cancer monitoring | CF |
04-09 | Guerbet: CE certificate for a platform | CF |
Sales 2022 | 3.79M 4.05M 325M | Sales 2023 | 3.3M 3.53M 283M | Capitalization | 18.8M 20.1M 1.61B |
---|---|---|---|---|---|
Net income 2022 | -3M -3.21M -257M | Net income 2023 | -3M -3.21M -257M | EV / Sales 2022 | 2.85 x |
Net Debt 2022 | 650K 695K 55.66M | Net cash position 2023 | 3.06M 3.28M 262M | EV / Sales 2023 | 4.76 x |
P/E ratio 2022 |
-2.97
x | P/E ratio 2023 |
-5.16
x | Employees | 74 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 44.57% |
1 day | -3.66% | ||
1 week | -2.77% | ||
Current month | +37.39% | ||
1 month | +49.06% | ||
3 months | -2.47% | ||
6 months | -26.51% | ||
Current year | -12.22% |
Managers | Title | Age | Since |
---|---|---|---|
Nicolas Reymond
CEO | Chief Executive Officer | 42 | 11/02/18 |
Julien Coste
DFI | Director of Finance/CFO | - | - |
Frédéric Champ
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michèle Lesieur
CHM | Chairman | 65 | 07/10/20 |
Patrice Rullier
BRD | Director/Board Member | 63 | 14/03/19 |
Nicolas Reymond
CEO | Chief Executive Officer | 42 | 11/02/18 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.316 | -3.66% | 49,262 |
25/04/24 | 0.328 | -1.20% | 45,402 |
24/04/24 | 0.332 | +1.84% | 12,525 |
23/04/24 | 0.326 | -1.21% | 3,451 |
22/04/24 | 0.33 | +1.54% | 11,327 |
Real-time Euronext Paris, April 26, 2024 at 03:54 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-12.22% | 17.61M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- ALINS Stock